ARCHIVES

Avastin improves lung cancer survival, opens options for new combinations. Details of Avastin risk vs. benefit to be released at ASCO annual meeting.

This article is from The Cancer Letter archive.

Vol. 31 No. 13 | April 1, 2005

Download PDF Visit The Full Archive

Related Articles

Two-Week Break Balances RT Palliation, Side Effects

February 26, 2010

Perjeta Neoadjuvant Therapy Granted Accelerated Approval In HER2 Breast Cancer

October 25, 2013

OSI “Front Line Office” In Probes Of Scientific Misconduct, Kimes Tells NCAB

October 13, 1989

Groups Urge Congress To Enact NIH Budget Increase; Encourage Individual Letters

November 3, 1995

AIDS Biological Specimens Available From NIH

November 22, 1985

Virus Program Report On Scientific Activities

August 15, 1975